Displaced Greater Tuberosity Fractures With Rotator Cuff Injury
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorGuo Jialiang
About this trial
Study Type: Prospective, three-arm parallel randomized controlled trial (RCT) Study Objective: To compare the 12-month/5 years/10years functional outcomes, morphological healing, cost-effectiveness, and complication rates of three treatment strategies for displaced greater tuberosity (GT) fractures with rotator cuff injury, and to optimize the individualized treatment strategy for GT fractures.
Study Setting: multicenter clinical trial, conducted in the Department of Orthopedics.
Study Period: April 2026 -April 2036.
Eligibility criteria
Qualifiers
• Age 18-76 years, male or female;
Diagnosed with displaced GT fracture (displacement distance ≥1mm) combined with rotator cuff injury (partial tear or full-thickness tear) by computed tomography (CT) or magnetic resonance imaging (MRI);
Time from fracture to admission ≤72 hours (acute phase);
No severe heart, liver, kidney or other underlying diseases, and able to cooperate with 12-month complete follow-up;
Disqualifiers
• Pathological fracture or old fracture (>3 weeks);
Complicated with shoulder dislocation or other proximal humeral fractures;
Previous shoulder surgery history, rheumatoid arthritis, or severe osteoporosis;
Mental illness, cognitive impairment, unable to complete functional scoring;
Trial design
Treatments tested in this trial
- Arthroscopic surgery
Treatment groups
180 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Guo Jialiang
Lead sponsor
Hebei Medical University Third Hospital
Sponsor institution
Source ClinicalTrials.gov